Balcioǧlu, A. S. Et Al. 2022. Dapagliflozin Improves Cardiac Autonomic Function Measures in Type 2 Diabetic Patients with Cardiac Autonomic Neuropathy. Anatolian Journal of Cardiology , vol.26, no.11 , 832-840.

Balcioǧlu, A. S., Çelik, E., Sahin, M., Göçer, K., Aksu, E., & Aykan, A. Ç., (2022). Dapagliflozin Improves Cardiac Autonomic Function Measures in Type 2 Diabetic Patients with Cardiac Autonomic Neuropathy. Anatolian Journal of Cardiology , vol.26, no.11, 832-840.

Balcioǧlu, Akif Et Al. "Dapagliflozin Improves Cardiac Autonomic Function Measures in Type 2 Diabetic Patients with Cardiac Autonomic Neuropathy," Anatolian Journal of Cardiology , vol.26, no.11, 832-840, 2022

Balcioǧlu, Akif S. Et Al. "Dapagliflozin Improves Cardiac Autonomic Function Measures in Type 2 Diabetic Patients with Cardiac Autonomic Neuropathy." Anatolian Journal of Cardiology , vol.26, no.11, pp.832-840, 2022

Balcioǧlu, A. S. Et Al. (2022) . "Dapagliflozin Improves Cardiac Autonomic Function Measures in Type 2 Diabetic Patients with Cardiac Autonomic Neuropathy." Anatolian Journal of Cardiology , vol.26, no.11, pp.832-840.

@article{article, author={Akif Serhat Balcioǧlu Et Al. }, title={Dapagliflozin Improves Cardiac Autonomic Function Measures in Type 2 Diabetic Patients with Cardiac Autonomic Neuropathy}, journal={Anatolian Journal of Cardiology}, year=2022, pages={832-840} }